Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05799222 · ClinicalTrials.gov registry record
Medically Intensive Nutrition Therapy Program for Obesity and Diabetes in a Low-income Population
A clinical trial of Obesity and Overweight, sponsored by Massachusetts General Hospital.
- Recruiting
- Registry status
- 20
- Enrollment target
- 1
- Study location
NCT05799222: Recruiting study of Obesity and Overweight, sponsored by Massachusetts General Hospital.
NCT05799222 is a study of Obesity and Overweight that is actively recruiting participants, run by Massachusetts General Hospital. The registered enrollment target is 20 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05799222, a study of Obesity and Overweight, is actively recruiting participants, sponsored by Massachusetts General Hospital.
- RECRUITING
- Registry status
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is being done to better understand whether meal replacements can be an effective tool for weight loss and treatment of elevated blood sugars in people with obesity/overweight and diabetes/pre-diabetes who have a low income.
Primary Outcome
Reduction in body weight by greater than or equal to 5 percent
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Bariatrix Meal Replacement Products
Study Locations (1)
Massachusetts
- Massachusetts General Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2023-03-28 |
| Est. Completion | 2026-11-10 |
What NCT05799222 shows while recruiting
NCT05799222 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (98% lower).
The record links to 4 conditions, with Obesity appearing as the primary indexed condition, and to 1 intervention - of which Bariatrix Meal Replacement Products is the first listed.
NCT05799222 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT05799222 about?
NCT05799222 is a clinical study titled "Medically Intensive Nutrition Therapy Program for Obesity and Diabetes in a Low-income Population". This study is being done to better understand whether meal replacements can be an effective tool for weight loss and treatment of elevated blood sugars in people with obesity/overweight and diabetes/pre-diabetes who have a low income.
What is the current status of trial NCT05799222?
This trial is currently recruiting. The enrollment target is 20 participants. The study started on 2023-03-28. Estimated completion is 2026-11-10.
What conditions does trial NCT05799222 study?
This clinical trial studies the following conditions: Obesity, Overweight, PreDiabetes, Diabetes Type 2.
What interventions are being tested in trial NCT05799222?
The interventions under investigation include: Bariatrix Meal Replacement Products (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05799222?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05799222 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05799222's enrollment target sits among peer trials
20 946th of 1053 higher than 80 of 1,053 other Obesity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Hip Flexion Feedback System for Exercise Monitoring in Individuals With Osteoarthritis and Obesity
RECRUITING · Phase 1
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial
RECRUITING · NA
-
TIRzepatide for the Treatment of Obesity in Patients With Atrial Fibrillation
RECRUITING · Phase 2
-
Tirzepatide: Reversal of Lipotoxicity and Adipose Tissue Dysfunction in Humans With Overweight/Obesity
RECRUITING · Phase 2
-
Tai Chi as a Novel Strategy to Increase Physical Activity Among Adults Pursuing Metabolic and Bariatric Surgery
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI